世界の髄膜炎菌ワクチン市場2020-2027:血清型別(MenACWY、MenB/BC、MenC、MenAC、MenA)、ワクチン種類別、エンドユーザー別、地域別

◆英語タイトル:Global Meningococcal Vaccine Market by Serogroup (MenACWY, MenB/BC, MenC, MenAC, and MenA), Vaccine Type (Conjugate, Polysaccharide, and Subcapsular), and End User (Pediatric, Adults, and Travelers) and Regional Forecasting 2020-2027
◆商品コード:BZW21AP057
◆発行会社(リサーチ会社):Bizwit Research&Consulting
◆発行日:2021年2月15日
◆ページ数:約200
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:アメリカ、カナダ、イギリス、ドイツ、フランス、スペイン、イタリア、中国、インド、日本、オーストラリア、韓国、ブラジル、メキシコ、GCC諸国
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD4,950 ⇒換算¥544,500見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD6,250 ⇒換算¥687,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はBizwit Research&Consulting社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Bizwit Research&Consulting社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本書では、世界の髄膜炎菌ワクチン市場を調査対象とし、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、ワクチン血清型別(MenACWY、MenB・マニック、MenC、MenA、MenAC)分析、ワクチン種類別(結合型、多糖類型、被膜下型)分析、エンドユーザー別(小児、成人、旅行者)分析、地域別分析、競争状況、調査プロセスなどを整理しました。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・世界の髄膜炎菌ワクチン市場規模:ワクチン血清型別(MenACWY、MenB・マニック、MenC、MenA、MenAC)
・世界の髄膜炎菌ワクチン市場規模:ワクチン種類別(結合型、多糖類型、被膜下型)
・世界の髄膜炎菌ワクチン市場規模:エンドユーザー別(小児、成人、旅行者)
・世界の髄膜炎菌ワクチン市場規模:地域別
・競争状況
・調査プロセス
【レポートの概要】

Global Meningococcal Vaccine Market was valued at USD 2.11 Billion in 2019 and expected to grow with a CAGR 9.5% over the forecast period 2020-2027. Meningococcal Vaccine is used in Invasive meningococcal disease. Invasive meningococcal disease (IMD) is a bacterial virus with a variety of diseases involving meningitis, bacteremia (meningococcemia), and bacteremia pneumonia affected by a gram-negative coccus, Neisseria meningitidis. The meningococcal disease is rare, if left unchecked, it is associated with a high mortality risk of up to 50% and commonly leads to severe complications afterwards.

The disease is usually spread by patients or asymptomatic carriers via close contact with droplets of respiratory or throat secretions. N. (Neisseria)Various serotypes of N. Meningitidis are found in 12 serogroups, of which only 5 serogroups are responsible for most of diseases worldwide, including A, B, C, W, and Y. Surge in immunization programs across the globe and increase in outbreaks of meningococcal disease drive the market globally. For instance, as per the World Health Organisation, Meningococcal meningitis is observed worldwide but highly sub-Saharan Africa and stretching from Senegal in the west to Ethiopia in the east affected from this diseased, around 30000 cases are still recorded each year in these areas. Furthermore, increase in research and development for vaccine technology also propel market growth. Despite that, longer timelines required for vaccine production and high costs associated with the development of vaccines restraint the market growth over the forecasting period 2020-2027.

The regional analysis of the Meningococcal Vaccine Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. In which, North America and Europe dominate the market owing to surge in outbreaks for meningococcal diseases and awareness for meningococcal diseases, ease of product availability in these regions. However, APAC is registered the fastest growth due to steady meningococcal vaccine market growth in the region.

Key Players in Global Meningococcal Vaccine Market:
Bio-Manguinhos
Bio-Med Pvt. Limited
Chongqing Zhifei Biological Products Co., Ltd.
GlaxoSmithKline Plc
Hualan Biological Engineering Inc.
Incepta Pharmaceuticals Ltd.
Pfizer Inc.
Sanofi S.A
Serum institute of India Pvt. Ltd
Walvax Biotechnology Co., Ltd

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Vaccine Serotype:
MenACWY
MenB & Manic
MenC
MenA
MenAC

By Vaccine Type:
Conjugate
Polysaccharide
Subcapsular

By End Users:
Paediatric
Adult
Travelers

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
Asia Pacific
China
India
Japan
Australia
Latin America
Brazil
Mexico
Rest of LA
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027

Target Audience of Global Meningococcal Vaccine Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

【レポートの目次】

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Meningococcal Vaccine Market, by Vaccine Serotype, 2018-2027 (USD Billion)
1.2.2. Meningococcal Vaccine Market, by Vaccine Type, 2018-2027 (USD Billion)
1.2.3. Meningococcal Vaccine Market, by End Users, 2018-2027 (USD Billion
1.2.4. Meningococcal Vaccine Market, By Region, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Meningococcal Vaccine Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Meningococcal Vaccine Market Dynamics
3.1. Meningococcal Vaccine Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Meningococcal Vaccine Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economic
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.1. Global Meningococcal Vaccine Market, by Vaccine Serotype
4.2. Market Snapshot
4.3. Global Meningococcal Vaccine Market by Source, Performance – Potential Analysis
4.4. Global Meningococcal Vaccine Market Estimates & Forecasts by Vaccine Serotype 2018-2027 (USD Billion)
4.5. Meningococcal Vaccine Market, Sub Segment Analysis
4.5.1. MenACWY
4.5.2. MenB & Manic
4.5.3. MenC
4.5.4. MenA
4.5.5. MenAC
Chapter 5. Global Meningococcal Vaccine Market, by Vaccine Type
5.1. Market Snapshot
5.2. Global Meningococcal Vaccine Market by Source, Performance – Potential Analysis
5.3. Global Meningococcal Vaccine Market Estimates & Forecasts by Vaccine Type 2018-2027 (USD Billion)
5.4. Meningococcal Vaccine Market, Sub Segment Analysis
5.4.1. Conjugate
5.4.2. Polysaccharide
5.4.3. Subcapsular
Chapter 6. Global Meningococcal Vaccine Market, by End Users
6.1. Market Snapshot
6.2. Global Meningococcal Vaccine Market by Source, Performance – Potential Analysis
6.3. Global Meningococcal Vaccine Market Estimates & Forecasts by End Users 2018-2027 (USD Billion)
6.4. Meningococcal Vaccine Market, Sub Segment Analysis
6.4.1. Paediatric
6.4.2. Adult
6.4.3. Travelers
Chapter 7. Global Meningococcal Vaccine Market, Regional Analysis
7.1. Meningococcal Vaccine Market, Regional Market Snapshot
7.2. North America Meningococcal Vaccine Market
7.2.1. U.S. Meningococcal Vaccine Market
7.2.1.1. Vaccine Serotype breakdown estimates & forecasts, 2018-2027
7.2.1.2. Vaccine Type breakdown estimates & forecasts, 2018-2027
7.2.1.3. End Users breakdown estimates & forecasts, 2018-2027
7.2.2. Canada Meningococcal Vaccine Market
7.3. Europe Meningococcal Vaccine Market Snapshot
7.3.1. U.K. Meningococcal Vaccine Market
7.3.2. Germany Meningococcal Vaccine Market
7.3.3. France Meningococcal Vaccine Market
7.3.4. Spain Meningococcal Vaccine Market
7.3.5. Italy Meningococcal Vaccine Market
7.3.6. Rest of Europe Meningococcal Vaccine Market
7.4. Asia-Pacific Meningococcal Vaccine Market Snapshot
7.4.1. China Meningococcal Vaccine Market
7.4.2. India Meningococcal Vaccine Market
7.4.3. Japan Meningococcal Vaccine Market
7.4.4. Australia Meningococcal Vaccine Market
7.5. Latin America Meningococcal Vaccine Market Snapshot
7.6. Rest of The World Meningococcal Vaccine Market
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profile
8.2.1. Bio-Manguinhos
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Bio-Med Pvt. Limited
8.2.3. Chongqing Zhifei Biological Products Co., Ltd.
8.2.4. GlaxoSmithKline Plc
8.2.5. Hualan Biological Engineering Inc.
8.2.6. Incepta Pharmaceuticals Ltd.
8.2.7. Pfizer Inc.
8.2.8. Sanofi S.A
8.2.9. Serum institute of India Pvt. Ltd
8.2.10. Walvax Biotechnology Co., Ltd.
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption

List of Tables
TABLE 1. Global Meningococcal Vaccine Market, report scope
TABLE 2. Global Meningococcal Vaccine Market estimates & forecasts by region 2018-2027 (USD Billion)
TABLE 3. Global Meningococcal Vaccine Market estimates & forecasts by Vaccine Serotype, 2018-2027 (USD Billion)
TABLE 4. Global Meningococcal Vaccine Market estimates & forecasts by Vaccine Type, 2018-2027 (USD Billion)
TABLE 5. Global Meningococcal Vaccine Market estimates & forecasts by End Users, 2018-2027 (USD Billion)
TABLE 6. Global Meningococcal Vaccine Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 7. Global Meningococcal Vaccine Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 8. Global Meningococcal Vaccine Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 9. Global Meningococcal Vaccine Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 10. Global Meningococcal Vaccine Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 11. Global Meningococcal Vaccine Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 12. Global Meningococcal Vaccine Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 13. Global Meningococcal Vaccine Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 14. Global Meningococcal Vaccine Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 15. Global Meningococcal Vaccine Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 16. Global Meningococcal Vaccine Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 17. Global Meningococcal Vaccine Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 18. Global Meningococcal Vaccine Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 19. Global Meningococcal Vaccine Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 20. Global Meningococcal Vaccine Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 21. Global Meningococcal Vaccine Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 22. U.S. Meningococcal Vaccine Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 23. U.S. Meningococcal Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 24. U.S. Meningococcal Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 25. Canada Meningococcal Vaccine Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 26. Canada Meningococcal Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 27. Canada Meningococcal Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 28. UK Meningococcal Vaccine Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 29. UK Meningococcal Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 30. UK Meningococcal Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 31. Germany Meningococcal Vaccine Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 32. Germany Meningococcal Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 33. Germany Meningococcal Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 34. France Meningococcal Vaccine Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 35. France Meningococcal Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 36. France Meningococcal Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 37. Spain Meningococcal Vaccine Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 38. Spain Meningococcal Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 39. Spain Meningococcal Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 40. Italy Meningococcal Vaccine Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 41. Italy Meningococcal Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 42. Italy Meningococcal Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 43. China Meningococcal Vaccine Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 44. China Meningococcal Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 45. China Meningococcal Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 46. India Meningococcal Vaccine Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 47. India Meningococcal Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 48. India Meningococcal Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 49. Japan Meningococcal Vaccine Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 50. Japan Meningococcal Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 51. Japan Meningococcal Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 52. Australia Meningococcal Vaccine Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 53. Australia Meningococcal Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 54. Latin America Meningococcal Vaccine Market estimate & forecasts, 2018-2027 (USD Billion)
TABLE 55. ROW Meningococcal Vaccine Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 56. ROW Meningococcal Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 57. ROW Meningococcal Vaccine Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 58. List of secondary sources, used in the study of global Meningococcal Vaccine Market
TABLE 59. List of primary sources, used in the study of global Meningococcal Vaccine Market
TABLE 60. Years considered for the study
TABLE 61. Exchange rates considered

List of figures
FIG 1. Global Meningococcal Vaccine Market, research methodology
FIG 2. Global Meningococcal Vaccine Market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Meningococcal Vaccine Market, key trends 2018
FIG 5. Global Meningococcal Vaccine Market, growth prospects 2018-2027
FIG 6. Global Meningococcal Vaccine Market, porters 5 force model
FIG 7. Global Meningococcal Vaccine Market, pest analysis
FIG 8. Global Meningococcal Vaccine Market, value chain analysis
FIG 9. Global Meningococcal Vaccine Market by segment, 2018 & 2027 (USD Billion)
FIG 10. Global Meningococcal Vaccine Market by segment, 2018 & 2027 (USD Billion)
FIG 11. Global Meningococcal Vaccine Market by segment, 2018 & 2027 (USD Billion)
FIG 12. Global Meningococcal Vaccine Market by segment, 2018 & 2027 (USD Billion)
FIG 13. Global Meningococcal Vaccine Market by segment, 2018 & 2027 (USD Billion)
FIG 14. Global Meningococcal Vaccine Market by segment, 2018 & 2027 (USD Billion)
FIG 15. Global Meningococcal Vaccine Market by segment, 2018 & 2027 (USD Billion)
FIG 16. Global Meningococcal Vaccine Market by segment, 2018 & 2027 (USD Billion)
FIG 17. Global Meningococcal Vaccine Market, regional snapshot 2018 & 2027
FIG 18. North America Meningococcal Vaccine Market 2018 & 2027 (USD Billion)
FIG 19. Europe Meningococcal Vaccine Market 2018 & 2027 (USD Billion)
FIG 20. Asia-Pacific Meningococcal Vaccine Market 2018 & 2027 (USD Billion)
FIG 21. Latin America Meningococcal Vaccine Market 2018 & 2027 (USD Billion)
FIG 22. Global Meningococcal Vaccine Market, company market share analysis (2018)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の髄膜炎菌ワクチン市場2020-2027:血清型別(MenACWY、MenB/BC、MenC、MenAC、MenA)、ワクチン種類別、エンドユーザー別、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆